Theriva Biologics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Theriva Biologics, Inc. (TOVX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $9.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2019-11-04.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2019-11-04
- Theriva Biologics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2018-03-31 was $9.00K.
- Theriva Biologics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2016 was $15.67M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2018-03-31 | $9.00K 10-Q · filed 2019-11-04 | |
| 2016-12-31 | $15.67M 10-K · filed 2018-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |